| 20.03.2025 11:10 | NFX | Result of AGM | RNS |
| 13.03.2025 14:41 | VIP, SUPR, NFX | UK shareholder meetings calendar - next 7 days | Alliance |
| 28.02.2025 12:30 | NFX | Total Voting Rights | RNS |
| 14.02.2025 14:18 | NFX | Posting of Annual Report and Notice of AGM | RNS |
| 30.01.2025 07:00 | NFX | £168,750 Placing | RNS |
| 29.01.2025 15:48 | NFX, ASIA, PGH | EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix | Alliance |
| 29.01.2025 07:00 | NFX | Annual Results for period ended 30 September 2024 | RNS |
| 28.01.2025 07:00 | NFX | NXP002 ODD Application Submitted | RNS |
| 13.01.2025 12:50 | NFX, MKA, COBR | TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal | Alliance |
| 13.01.2025 07:00 | NFX | NXP002 Orphan Drug Designation Draft Application | RNS |
| 29.11.2024 17:00 | NFX | Total Voting Rights | RNS |
| 05.11.2024 14:25 | NFX | Director/PDMR Dealings | RNS |
| 04.11.2024 10:17 | NFX | Result of General Meeting | RNS |
| 28.10.2024 12:27 | NFX, BASC | UK shareholder meetings calendar - next 7 days | Alliance |
| 16.10.2024 13:37 | NFX | Publication of Prospectus & Notice of GM | RNS |
| 20.09.2024 14:24 | NFX | £300,000 Fundraise | RNS |
| 18.06.2024 18:37 | NFX | IN BRIEF: Nuformix shares fall despite interim loss narrowing | Alliance |
| 18.06.2024 07:00 | NFX | Half-year Report | RNS |
| 17.06.2024 10:37 | NFX | Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment | Alliance |
| 17.06.2024 07:00 | NFX | Patent Update | RNS |
| 19.03.2024 14:39 | NFX | Result of AGM | RNS |
| 12.03.2024 14:30 | VARE, NFX, GV2O | UK shareholder meetings calendar - next 7 days | Alliance |
| 01.03.2024 10:31 | NFX | IN BRIEF: Nuformix announces subscription to raise GBP150,000 | Alliance |
| 01.03.2024 07:00 | NFX | Subscription to raise £150,000 | RNS |
| 15.01.2024 11:30 | NFX | Posting of Annual Report and Notice of AGM | RNS |
| 03.01.2024 10:16 | AZN, NFX | IN BRIEF: Nuformix narrows annual loss as develops drug assets | Alliance |
| 03.01.2024 07:00 | NFX | Results for the period ended 30 September 2023 | RNS |
| 18.12.2023 07:00 | NFX | NXP001 Update | RNS |
| 23.10.2023 12:38 | NFX | Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002 | Alliance |
| 23.10.2023 07:00 | NFX | Notice of Allowance of NXP002 Patent in Japan | RNS |
| 18.09.2023 10:20 | NFX | IN BRIEF: Nuformix to receive milestone payments from Oxilio pact | Alliance |
| 18.09.2023 07:00 | NFX | NXP001 Update | RNS |
| 24.08.2023 13:22 | NFX | Result of Annual General Meeting | RNS |
| 17.08.2023 15:43 | OIG, NFX, CYAN | UK shareholder meetings calendar - next 7 days | Alliance |
| 31.07.2023 14:00 | NFX | Notice of AGM | RNS |
| 26.07.2023 14:55 | NFX | Holding(s) in Company | RNS |
| 02.06.2023 07:00 | NFX | Investor Online Q&A | Reach |
| 25.05.2023 07:00 | NFX | Change of Auditor | RNS |
| 22.05.2023 12:45 | NFX | Nuformix loss narrows; near-term goal to focus on NXP002 asset | Alliance |
| 22.05.2023 07:00 | NFX | Unaudited Interim Report | RNS |
| 18.05.2023 14:31 | ARV, STB, CIC | TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect | Alliance |
| 18.05.2023 07:00 | NFX | NXP002 Inflammation and Duration of Action Update | RNS |
| 26.04.2023 10:55 | NFX | Holding(s) in Company | RNS |
| 17.04.2023 12:14 | NFX | Nuformix raises GBP70,000 to fund NXP002 programme | Alliance |
| 17.04.2023 07:00 | NFX | Subscription to raise £70,000 & issue of Warrants | RNS |
| 27.03.2023 18:42 | NFX, TSTL, AGY | TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy | Alliance |
| 27.03.2023 07:00 | NFX | NXP002 Update | RNS |
| 13.03.2023 07:00 | NFX | Change of Accounting Reference Date | RNS |
| 15.02.2023 12:12 | NFX | Nuformix progresses NXP002 trial after acquiring human tissue | Alliance |
| 15.02.2023 07:00 | NFX | NXP002 Update | Reach |
| 03.01.2023 13:37 | NFX | Holding(s) in Company | RNS |
| 20.12.2022 13:00 | NFX | EQS-News: Nuformix hoping to 'initiate discussions with major pharma' in 2023 | EQS |
| 20.12.2022 07:00 | NFX | NXP004 Update | RNS |
| 13.12.2022 14:54 | NFX | Nuformix interim loss virtually flat as continues work on drugs | Alliance |
| 13.12.2022 07:00 | NFX | Half-year Report | RNS |
| 05.12.2022 07:00 | NFX | Resignation of Auditor | RNS |
| 16.11.2022 08:50 | NFX | Holding(s) in Company | RNS |
| 04.11.2022 07:00 | NFX | Investor Webinar | Reach |
| 23.09.2022 21:02 | HBR, RKH, FCH | TRADING UPDATES: Neometals swings to loss; Funding Circle strikes deal | Alliance |
| 23.09.2022 07:00 | NFX | NXP002 Update | RNS |
| 25.08.2022 14:39 | NFX | Result of AGM | RNS |
| 19.08.2022 08:57 | NFX | Holding(s) in Company | RNS |
| 18.08.2022 16:01 | NFX, NWG, MCB | UK shareholder meetings calendar - next 7 days | Alliance |
| 10.08.2022 11:14 | NFX | IN BRIEF: Nuformix shares rise on tolerability studies completion | Alliance |
| 10.08.2022 07:00 | NFX | NXP002 Completion of Tolerability Studies | RNS |
| 01.08.2022 12:13 | NFX | Posting of Annual Report and Notice of AGM | RNS |
| 28.07.2022 16:14 | NFX, CHRT, CPI | EXECUTIVE CHANGES: Cohort co-founder out; Nuformix co-founder back | Alliance |
| 28.07.2022 15:01 | NFX | EARNINGS UPDATES: Alliance Trust beats benchmark and ups dividend | Alliance |
| 28.07.2022 07:01 | NFX | Board Changes | RNS |
| 28.07.2022 07:00 | NFX | Annual Results for the year ended 31 March 2022 | RNS |
| 05.07.2022 07:00 | NFX | NXP002 data to be presented at 2022 ERS Congress | Reach |
| 29.06.2022 12:25 | AZN, NFX | IN BRIEF: Nuformix shares rise as progresses with cancer programme | Alliance |
| 29.06.2022 07:00 | NFX | NXP004 Update | RNS |
| 27.06.2022 21:51 | SYM, SRES, BELL | TRADING UPDATES: Anglo-Eastern Plantations sees palm oil prices rise | Alliance |
| 27.06.2022 07:00 | NFX | NXP002 Update | RNS |
